1,458,9711,857,118(1) Financial information is extracted from the audited financial statements included in the Company's fiscal year 2011 20F.(2) Restricted cash and restricted investment are those purchase consideration in connection with our acquisition being held on escrow accounts.
Exhibit 2MINDRAY MEDICAL INTERNATIONAL LIMITEDCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Dollars in thousands, except for share and per share data)Three months ended December 31,Year ended December 31,2011201220112012US$ US$ US$ US$ (unaudited) (unaudited) (Note 1) (unaudited) Net revenues-PRC117,630148,136374,312472,991- International 146,500167,980506,431587,063Net revenues264,130316,116880,7431,060,054Cost of revenues (121,035)(133,355)(394,302)(459,389)Gross profit143,095182,761486,441600,665Selling expenses (51,917)(53,688)(167,049)(188,804)General and administrative expenses (17,689)(36,467)(70,330)(116,228)Research and development expenses (25,589)(32,926)(82,024)(104,302)Operating income47,90059,680167,038191,331Other income, net5161773,1081,619Interest income7,2587,94920,81630,794Interest expense(470)(1,028)(1,390)(4,093)Income before income taxes and non-controlling interests55,20466,778189,572219,651Provision for income taxes(8,220)(9,895)(22,647)(37,369)Net income 46,98456,883166,925182,282Less: Net income attributable to non-controlling interests(189)(1,034)(296)(2,073)Net income attributable to the Company46,79555,849166,629180,209Basic earnings per share0.410.481.451.54Diluted earnings per share0.400.471.411.50Shares used in the computation of:Basic earnings per share115,466,221117,358,594115,254,095116,749,213Diluted earnings per share118,365,008120,099,229118,449,851119,815,004(1) Financial information is extracted from the audited financial statements included in the Company's fiscal year 2011 20F.
|SOURCE Mindray Medical International Limited|
Copyright©2012 PR Newswire.
All rights reserved